Status:

UNKNOWN

the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients

Lead Sponsor:

Central Hospital, Nancy, France

Conditions:

Cholangiocarcinoma

Eligibility:

All Genders

18+ years

Brief Summary

The prognosis for cholangiocarcinoma is bad. Potentially, early management by a palliative care team could increase overall survival. We will also assess whether early management by a palliative care ...

Eligibility Criteria

Inclusion

  • Age\> 18 years old
  • intra- or extra-hepatic CCK or histologically proven vesicular adenocarcinoma
  • Locally advanced and / or metastatic disease from the start or recurrent
  • Initial diagnosis or recurrence between 1/01/2013 and 31/12/2019

Exclusion

  • \<18 years old
  • death less than one week after the diagnostic

Key Trial Info

Start Date :

June 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2020

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04415190

Start Date

June 1 2020

End Date

December 31 2020

Last Update

June 4 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lopez

Vandœuvre-lès-Nancy, France, 54500

the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients | DecenTrialz